Cord Blood America Chairman and CEO to Present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference

Los Angeles, California, UNITED STATES


LOS ANGELES, Nov. 2, 2005 (PRIMEZONE) -- Cord Blood America, Inc. (OTCBB:CBAI), an umbilical cord blood stem cell preservation company, is pleased to announce that Mr. Matthew Schissler, Chairman and CEO of Cord Blood America will make a presentation at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference.

This year's conference is being held at the New York Palace Hotel in New York City. The conference which attracts over 2000 attendees yearly will be held on November 7-9, 2005.

Mr. Schissler is scheduled to present on Tuesday, November 8, 2005 at 4:15 p.m. in the Holmes 1 room at the New York Palace Hotel.

For more information about the conference or to register to attend please feel free to visit the official site of the conference at: http://www.rodmanandrenshaw.com/rodman.asp?link=Conferences7/ConferenceMain&bgcolor=wht

This press release is available on the Cord Blood America IR HUB for investor commentary, feedback and questions. Investors are asked to visit http://www.agoracom.com/IR/CordBloodAmerica . Alternatively, investors are asked to e-mail all questions and correspondence to CBAI@agoracom.com where they can also request addition to the investor e-mail list to receive all future press releases and correspondence directly.

About Cord Blood America

Cord Blood America (OTCBB:CBAI) is the parent company of Cord Partners, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and life-saving resource for treating a growing number of ailments, including cancer, leukemia, or blood and immune disorders. For more information on how this precious lifeline can benefit your family, visit www.cordpartners.com.

Forward-Looking Statements

This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. Forward-looking statements include, without limitation, our ability to increase income streams, to grow revenue and earnings, and to obtain additional cord blood banking revenue streams. These statements are only predictions and are subject to certain risks, uncertainties and assumptions, which are identified and described in the Company's public filings with the Securities and Exchange Commission.



        

Contact Data